Array BioPharma To Present at the Jefferies 2018 Global Healthcare Conference

BOULDER, Colo., May 30, 2018 /PRNewswire/ -- Array BioPharma Inc. (Nasdaq:ARRY) today announced that its Chief Executive Officer, Ron Squarer, will speak at the Jefferies 2018 Global Healthcare Conference in New York. The public is welcome to participate in the conference through a webcast on the Array BioPharma website.   


Jefferies 2018 Global Healthcare Conference


Ron Squarer, Chief Executive Officer, Array BioPharma


Wednesday, June 6, 2018


2 p.m. Eastern Time


About Array BioPharma

Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer and other conditions. Ten registration studies are currently advancing related to eight Array-owned or partnered drugs: encorafenib (LGX818), binimetinib (MEK162), ARRY-797, selumetinib (partnered with AstraZeneca), danoprevir (partnered with Roche), ipatasertib (partnered with Genentech), larotrectinib (partnered with Loxo Oncology) and tucatinib (partnered with Seattle Genetics). For more information on Array, please go to


Andrea N. Flynn, Ph.D. 

Senior Director, Investor Relations & Corporate Communications 

(303) 381-6600


 View original content with multimedia:

SOURCE Array BioPharma

ShareThis Copy and Paste